INDISA Stock Overview
Provides health services in Chile. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Instituto de Diagnóstico S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CL$1,588.00 |
52 Week High | CL$1,626.20 |
52 Week Low | CL$1,199.20 |
Beta | 0.56 |
1 Month Change | 1.53% |
3 Month Change | 13.43% |
1 Year Change | 23.30% |
3 Year Change | -0.75% |
5 Year Change | -6.04% |
Change since IPO | 1,011.08% |
Recent News & Updates
We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings
Dec 10Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings
Jun 05Recent updates
We Think That There Are Issues Underlying Instituto de Diagnóstico's (SNSE:INDISA) Earnings
Dec 10Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings
Jun 05Slowing Rates Of Return At Instituto de Diagnóstico (SNSE:INDISA) Leave Little Room For Excitement
Sep 07Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly
Aug 17A Look At The Intrinsic Value Of Instituto de Diagnóstico S.A. (SNSE:INDISA)
May 19Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly
Apr 16Instituto de Diagnóstico (SNSE:INDISA) Will Will Want To Turn Around Its Return Trends
May 06Is Instituto de Diagnóstico S.A. (SNSE:INDISA) A Strong Dividend Stock?
Mar 23Instituto de Diagnóstico S.A.'s (SNSE:INDISA) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?
Mar 02Is Instituto de Diagnóstico (SNSE:INDISA) Using Too Much Debt?
Feb 09Should We Be Excited About The Trends Of Returns At Instituto de Diagnóstico (SNSE:INDISA)?
Jan 25Instituto de Diagnóstico's(SNSE:INDISA) Share Price Is Down 37% Over The Past Three Years.
Jan 07Should You Use Instituto de Diagnóstico's (SNSE:INDISA) Statutory Earnings To Analyse It?
Dec 23What Kind Of Shareholders Own Instituto de Diagnóstico S.A. (SNSE:INDISA)?
Dec 06Are Poor Financial Prospects Dragging Down Instituto de Diagnóstico S.A. (SNSE:INDISA Stock?
Nov 20Shareholder Returns
INDISA | CL Healthcare | CL Market | |
---|---|---|---|
7D | -0.2% | -6.5% | -0.7% |
1Y | 23.3% | -28.8% | 8.7% |
Return vs Industry: INDISA exceeded the CL Healthcare industry which returned -31.1% over the past year.
Return vs Market: INDISA exceeded the CL Market which returned 9.4% over the past year.
Price Volatility
INDISA volatility | |
---|---|
INDISA Average Weekly Movement | 2.0% |
Healthcare Industry Average Movement | 6.5% |
Market Average Movement | 2.1% |
10% most volatile stocks in CL Market | 4.4% |
10% least volatile stocks in CL Market | 0.6% |
Stable Share Price: INDISA has not had significant price volatility in the past 3 months compared to the CL market.
Volatility Over Time: INDISA's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1961 | 2,985 | Manuel Serra Cambiaso | www.indisa.cl |
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and indication exams, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising online consultation and rehabilitation.
Instituto de Diagnóstico S.A. Fundamentals Summary
INDISA fundamental statistics | |
---|---|
Market cap | CL$223.80b |
Earnings (TTM) | CL$7.08b |
Revenue (TTM) | CL$235.31b |
31.6x
P/E Ratio1.0x
P/S RatioIs INDISA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
INDISA income statement (TTM) | |
---|---|
Revenue | CL$235.31b |
Cost of Revenue | CL$178.05b |
Gross Profit | CL$57.26b |
Other Expenses | CL$50.18b |
Earnings | CL$7.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 50.24 |
Gross Margin | 24.33% |
Net Profit Margin | 3.01% |
Debt/Equity Ratio | 88.7% |
How did INDISA perform over the long term?
See historical performance and comparisonDividends
0.02%
Current Dividend Yield0.6171%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 23:40 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Instituto de Diagnóstico S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Steffania Mosquera | CrediCorp Capital |
Daniel Velandia Ocampo | CrediCorp Capital |